Release Summary

Navidea reported Q2 2014 financial results with revenue to Navidea from sales of Lymphoseek® growing to more than $1 million in Q2/2014 and reiterated revenue expectation of $5-6M for full-year 2014.

Navidea Biopharmaceuticals, Inc.